2022 annual financial data
Kazia Therapeutics 2022 Operating margin
Direct answer
Operating margin was -253,990%.
Operating income was -25,399,000 AUD and net income was -25,014,000 AUD.
Operating cash flow was -22,762,000 AUD.
Get free Kazia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,000 AUD
- Operating income
- -25,399,000 AUD
- Net income
- -25,014,000 AUD
- Operating cash flow
- -22,762,000 AUD